Assyro AI

Orange Book product · Generic (ANDA)

SEVELAMER CARBONATE

SEVELAMER CARBONATE

Generic (ANDA)ANDA 217319TE ABRX CHARTWELL RX
View SEVELAMER CARBONATE familyOpen on FDA Orange Book

At a glance

Mar 02, 2023

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 02, 2023

    3 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SEVELAMER CARBONATE

Strength

2.4GM/PACKET

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

AB

Application

ANDA 217319

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SEVELAMER CARBONATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo